1B20 PCSK9 antagonists

Details for Australian Patent Application No. 2009212282 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Pandit, Shilpa; Sitlani, Ayesha; Wang, Kevin; Luo, Peter; Gregory, Sonia M.; Hammond, Holly A.; Wood, Dana D.; Condra, Jon H.; Zhong, Pingyu; Peterson, Laurence B.; Nawrocki, Denise K.; Cubbon, Rose M.; Blue, Jeffrey T.; McCabe, Timothy; Mach, Henryk; Yoder, Heidi; Li, Yan; Santoro, Joseph C.; Dong, Feng

Agent Spruson & Ferguson

Pub. Number AU-A-2009212282

PCT Pub. Number WO2009/100318

Priority 61/063,980 07.02.08 US

Filing date 6 February 2009

Wipo publication date 13 August 2009

International Classifications

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/100318 Priority application(s): WO2009/100318

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212286-Accommodative IOL with dynamic spherical aberration

2009212279-Energy absorbers, connectors and horizontal lifeline systems